Description: CSL Behring has developed several plasma-derived therapies for treating hereditary bleeding disorders. Learn more.
We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.